-
2 × $1,068.00
-
1 × $442.00
-
1 × $3,218.00
-
2 × $569.00
-
1 × $466.00
-
2 × $764.00
-
1 × $1,750.00
-
2 × $2,957.00
-
2 × $5,820.00
-
1 × $401.00
-
2 × $7,614.00
-
1 × $3,417.00
-
1 × $1,511.00
-
1 × $2,362.00
-
1 × $1,819.00
-
1 × $24,377.00
-
1 × $1,224.00
-
1 × $2,492.00
-
2 × $446.00
-
1 × $2,142.00
-
1 × $458.00
-
1 × $646.00
-
3 × $2,168.00
-
3 × $816.00
-
2 × $951.00
-
3 × $24,377.00
-
1 × $573.00
-
1 × $2,113.00
-
1 × $517.00
-
1 × $7,433.00
-
1 × $437.00
-
2 × $657.00
-
1 × $1,345.00
-
1 × $682.00
-
1 × $6,456.00
-
2 × $1,068.00
-
1 × $1,038.00
-
2 × $1,164.00
-
2 × $1,902.00
-
1 × $524.00
-
1 × $398.00
-
1 × $1,971.00
-
1 × $2,436.00
-
2 × $1,087.00
-
1 × $8,175.00
-
1 × $3,834.00
-
1 × $1,122.00
-
1 × $542.00
-
1 × $7,392.00
-
1 × $855.00
-
1 × $425.00
-
2 × $709.00
-
3 × $677.00
-
1 × $3,385.00
-
1 × $1,990.00
-
3 × $492.00
-
1 × $2,163.00
-
1 × $608.00
-
1 × $897.00
-
1 × $470.00
-
2 × $1,130.00
-
1 × $607.00
-
1 × $1,642.00
-
1 × $477.00
-
1 × $1,281.00
-
1 × $613.00
-
1 × $1,092.00
-
2 × $897.00
-
1 × $2,152.00
-
1 × $487.00
-
1 × $5,432.00
-
1 × $4,807.00
-
1 × $968.00
-
1 × $2,223.00
-
1 × $2,390.00
-
1 × $2,218.00
-
1 × $997.00
-
1 × $800.00
-
1 × $6,930.00
-
2 × $760.00
-
1 × $2,361.00
-
2 × $435.00
-
1 × $2,464.00
-
1 × $2,698.00
-
1 × $2,435.00
-
1 × $2,190.00
-
1 × $471.00
-
2 × $588.00
-
1 × $4,065.00
-
1 × $520.00
-
1 × $20,652.00
-
2 × $1,642.00
-
1 × $2,724.00
-
1 × $434.00
-
1 × $1,640.00
-
1 × $1,068.00
-
1 × $2,219.00
-
1 × $582.00
-
1 × $1,687.00
-
1 × $4,091.00
-
1 × $471.00
-
1 × $555.00
-
1 × $399.00
-
1 × $2,050.00
-
1 × $713.00
-
1 × $1,092.00
-
1 × $3,286.00
-
1 × $1,068.00
-
1 × $399.00
-
1 × $4,273.00
This item can only ship to a medical or educational facility.
The new wireless BD Veritor™ Plus System gives health care providers and laboratorians in physician offices, clinics, hospitals and Integrated Delivery Networks (IDNs) with objective, lab-quality immunoassay test results within minutes. This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The new system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), COVID-19 (SARS-2-COV) and group A strep while the patient is still on site, which can enable faster decision making for an earlier intervention opportunity.
Features and Benefits
- Faster access to test results: Help inform appropriate and targeted treatment decisions.
- Improved Workflow: The BD Veritor™ Plus Analyzer improves workflow with an Analyze Now or Walk Away mode, providing test results (with a printenabled function) and aiding in decision making while the patient is onsite.
- Improved Traceability: The optional BD Veritor™ InfoScan module can scan 3 different identifiers (operator ID, specimen ID and test kit /lot) that can be locally recorded, printed or downloaded, and reduces hands-on time through automated documentation
- Modularity: Provides a unique solution to meet each testing site’s preference
- Advanced particle technology: Enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles.
- Adaptive read technology: Compensates for background and non-specific binding helps improve specificity to reduce false-positive results
- BD Veritor SARS-CoV-2 & Flu A+B Rapid Detection Kit (Included): The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
Materials Included
- BD Veritor™ Plus System Anaylzer
- 2 AA Batteries
- 2 SARS-CoV-2 & Influenza A + B Rapid Detection Kit (30 Tests/Kits)
- User manual
CPT Code
- 87804-QW: Infectious agent antigen detection by immunoassay with direct optical observation, influenza A
- National Average Reimbursement: $16.00
- 878704-59: Infectious agent antigen detection by immunoassay with direct optical observation, influenza B
- National Average Reimbursement: $16.00
- 87426 – Infectious agent antigen detection by immunoassay technique (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative, multiple-step method, severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19])